drugset / Trial / NCT01060345

A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ

NCT01060345

Phase 2 Terminated 20 enrolled University of Chicago
NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to find molecular signs (biomarkers) to better understand the role of green tea as an anti-cancer and anti-inflammation agent in women with newly-diagnosed ductal carcinoma in situ (DCIS).

Timeline

Start
2010-05
Primary completion
2015-09
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Sinecatechins Unknown 600 mg Oral